CLICK HERE to listen to details from Radio Oklahoma’s Ann Roberts.
Experts say it could lead to a cure for Type 1 diabetes and it’s happening at OU Children’s Hospital. The patient at OU Children’s Hospital is the first to receive the drug Tzield, which slows down the progression of the disease.
Dr. David Sparling is leading the research. Experts say the drug can delay a patient’s need for insulin for up to 10 years, and believe it is the first step to the cure for Type 1 diabetes,
Commentaires